What Changed? As of January 22, 2026, Swissmedic announced a batch recall of Risperidon-Mepha LA Pulver…
Category: Switzerland
Switzerland updates on medical device regulation and quality.
Swissmedic Approves Redundancy Plan for Headcount Reduction
Swissmedic has finalized a redundancy scheme in response to an announced staff reduction at the organization.…
Swissmedic Expands Approval for Calquence® Therapeutic Indication
On January 15, 2026, Swissmedic officially approved an extension of the therapeutic indication for Calquence®, marking…
Temporary Authorization for Abilify i.m. Injection Solution Due to Supply Shortage
Swissmedic, Switzerland’s authority for therapeutic products, has announced the temporary authorization for the distribution of Abilify…
Swissmedic Confirms New Blood Donation Guidelines to Address vCJD Concerns
On February 1, 2026, new blood donation criteria from Swiss Transfusion SRC will take effect, marking…
Swissmedic welcomes Vincenza Trivigno as new Executive Director
On January 12, 2026, Swissmedic, the Swiss agency responsible for the authorization and monitoring of therapeutic…
Streamline Medical Device Registration with Swissmedic: Free Webinar Highlights swissdamed Tools
Swissmedic, Switzerland’s national agency for therapeutic products, is offering a complimentary webinar on May 28, 2026.…
Regulatory Update: Swissmedic Expands Therapeutic Indication for Jaypirca®
Swissmedic has announced an extension of the therapeutic indication for Jaypirca®, a development that could impact…
Swissmedic Announces Recall of Ringerfundin B. Braun Batch Due to Quality Issues
On January 10, 2026, Swissmedic issued an official recall notice regarding specific batches of Ringerfundin B.…